Lung Transplantation in Patients with Previous or Unknown Oncological Disease: Evaluation of Short- and Long-Term Outcomes
Authors:
- Chiara CatelliCCChiara Catelli
- Eleonora FaccioliEleonora Faccioli
- Stefano SilvestrinSSStefano Silvestrin
- Giulia LorenzoniGiulia Lorenzoni
- Luca LuzziLLLuca Luzzi
- David BennettDBDavid Bennett
- Marco SchiavonMSMarco Schiavon
- Alessio CampisiACAlessio Campisi
- Elena BargagliElena Bargagli
- Andrea Dell’amoreADAndrea Dell’amore
- Federico ReaFRFederico Rea
Open Access
Abstract
The accurate selection of the recipient is a crucial aspect in the field of lung transplantation (LTX), especially if patients were previously affected by oncological disease. The aim of this bicentric retrospective study was to evaluate short- and long-term outcomes in patients with previous oncological disease or unknown neoplasia found on native lungs submitted to LTX, compared to a control group. A total of 433 patients were included in the analysis, 31 with malignancies (Group 1) and 402 without neoplastic disease (Group 2). The two groups were compared in terms of short- and long-term outcomes. Patients in Group 1 were older (median age 58 years vs. 50 years, p = 0.039) and mostly affected by idiopathic pulmonary fibrosis (55% vs. 40% p = 0.002). Even though in Group 1 a lower rate of late post-operative complications was found (23% vs. 45%, p = 0.018), the median overall survival (OS) was lower compared to the control group (10 months vs. 29 months, p = 0.015). LTX represents a viable therapeutic option for patients with end-stage lung disease and a history of neoplastic disease. However, every case should be carefully debated in a multidisciplinary setting, considering oncological (histology, stage, and proper disease free-interval) and clinical factors (patient’s age and comorbidities). A scrupulous post-transplant follow-up is especially mandatory in those cases.Keywords
This publication has 27 references indexed in Scilit:
- Prevalence and outcome of lung cancer in lung transplant recipientsRespiratory Medicine, 2015
- Overall and Cause-Specific Mortality in Transplant Recipients with a Pretransplantation Cancer HistoryTransplantation, 2013
- Pre-transplant malignancy: An analysis of outcomes after thoracic organ transplantationThe Journal of Heart and Lung Transplantation, 2013
- Long-term follow-up of lung and heart transplant recipients with pre-transplant malignanciesThe Journal of Heart and Lung Transplantation, 2012
- Lung Cancer and Lung Transplantation: A ReviewJournal of Thoracic Oncology, 2009
- Chest and abdominal CT during extracorporeal membrane oxygenation: Clinical benefits in diagnosis and treatment1Academic Radiology, 2005
- Incidence of primary neoplasms in explanted lungs: Long-term follow-up from 214 lung transplant patientsTransplantation Proceedings, 2004
- Lung Cancer and Cryptogenic Fibrosing Alveolitis: A Population-based Cohort StudyAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Recurrence of Bronchioloalveolar Carcinoma in Transplanted LungsNew England Journal of Medicine, 1999
- Preoperative examination of lung transplant candidates: value of chest CT compared with chest radiography.American Journal of Roentgenology, 1995